Study protocol for an open labelled randomised controlled trial of perioperative oral nutrition supplement in breast and colorectal cancer patients undergoing elective surgery

Abstract Background While it is well established that perioperative use of oral nutrition supplement (ONS) improves nutrition status among severely malnourished surgical cancer patients, the evidence requires further substantiation for non-severely malnourished patients with cancer. This protocol pa...

Full description

Bibliographic Details
Main Authors: T. X. Wong, S. T. Chen, S. H. Ong, S. Shyam, P. Kandasami, W. S. S. Chee
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Trials
Subjects:
Online Access:https://doi.org/10.1186/s13063-021-05716-5
_version_ 1818983540605321216
author T. X. Wong
S. T. Chen
S. H. Ong
S. Shyam
P. Kandasami
W. S. S. Chee
author_facet T. X. Wong
S. T. Chen
S. H. Ong
S. Shyam
P. Kandasami
W. S. S. Chee
author_sort T. X. Wong
collection DOAJ
description Abstract Background While it is well established that perioperative use of oral nutrition supplement (ONS) improves nutrition status among severely malnourished surgical cancer patients, the evidence requires further substantiation for non-severely malnourished patients with cancer. This protocol paper presents the rationale and design of a randomised controlled trial to evaluate the effectiveness of preoperative as well as an extended 90-day postoperative use of ONS on nutritional and clinical outcomes among patients undergoing elective surgery for breast and colorectal cancer. Methods Patients with primary breast and colorectal cancer undergoing elective surgery are recruited from two tertiary hospitals. Eligible patients are assigned into one of the three intervention arms: (i) Group SS will receive ONS in addition to their normal diet up to 14 days preoperatively and postoperatively up to discharge; (ii) Group SS-E will receive ONS in addition to their normal diet up to 14 days preoperatively, postoperatively up to discharge and for an extended 90 days after discharge; and (iii) Group DS will receive ONS in addition to their normal diet postoperatively up to discharge from the hospital. The ONS is a standard formula fortified with lactium to aid in sleep for recovery. The primary endpoints include changes in weight, body mass index (BMI), serum albumin and prealbumin levels, while secondary endpoints are body composition (muscle and fat mass), muscle strength (handgrip strength), energy and protein intake, sleep quality, haemoglobin, inflammatory markers (transferrin, high sensitivity C-reactive protein, interleukin-6), stress marker (saliva cortisol), length of hospital stay and postoperative complication rate. Discussion This trial is expected to provide evidence on whether perioperative supplementation in breast and colorectal cancer patients presenting with high BMI and not severely malnourished but undergoing the stress of surgery would be beneficial in terms of nutritional and clinical outcomes. Trial registration ClinicalTrial.gov NCT04400552. Registered on 22 May 2020, retrospectively registered
first_indexed 2024-12-20T18:04:44Z
format Article
id doaj.art-10e4ef239f534c0fbec11c596b79c87d
institution Directory Open Access Journal
issn 1745-6215
language English
last_indexed 2024-12-20T18:04:44Z
publishDate 2021-11-01
publisher BMC
record_format Article
series Trials
spelling doaj.art-10e4ef239f534c0fbec11c596b79c87d2022-12-21T19:30:34ZengBMCTrials1745-62152021-11-0122111710.1186/s13063-021-05716-5Study protocol for an open labelled randomised controlled trial of perioperative oral nutrition supplement in breast and colorectal cancer patients undergoing elective surgeryT. X. Wong0S. T. Chen1S. H. Ong2S. Shyam3P. Kandasami4W. S. S. Chee5Division of Nutrition & Dietetics, School of Health Sciences, International Medical UniversityDivision of Nutrition & Dietetics, School of Health Sciences, International Medical UniversityDivision of Nutrition & Dietetics, School of Health Sciences, International Medical UniversityDivision of Nutrition & Dietetics, School of Health Sciences, International Medical UniversityDepartment of Surgery, School of Medicine, International Medical UniversityDivision of Nutrition & Dietetics, School of Health Sciences, International Medical UniversityAbstract Background While it is well established that perioperative use of oral nutrition supplement (ONS) improves nutrition status among severely malnourished surgical cancer patients, the evidence requires further substantiation for non-severely malnourished patients with cancer. This protocol paper presents the rationale and design of a randomised controlled trial to evaluate the effectiveness of preoperative as well as an extended 90-day postoperative use of ONS on nutritional and clinical outcomes among patients undergoing elective surgery for breast and colorectal cancer. Methods Patients with primary breast and colorectal cancer undergoing elective surgery are recruited from two tertiary hospitals. Eligible patients are assigned into one of the three intervention arms: (i) Group SS will receive ONS in addition to their normal diet up to 14 days preoperatively and postoperatively up to discharge; (ii) Group SS-E will receive ONS in addition to their normal diet up to 14 days preoperatively, postoperatively up to discharge and for an extended 90 days after discharge; and (iii) Group DS will receive ONS in addition to their normal diet postoperatively up to discharge from the hospital. The ONS is a standard formula fortified with lactium to aid in sleep for recovery. The primary endpoints include changes in weight, body mass index (BMI), serum albumin and prealbumin levels, while secondary endpoints are body composition (muscle and fat mass), muscle strength (handgrip strength), energy and protein intake, sleep quality, haemoglobin, inflammatory markers (transferrin, high sensitivity C-reactive protein, interleukin-6), stress marker (saliva cortisol), length of hospital stay and postoperative complication rate. Discussion This trial is expected to provide evidence on whether perioperative supplementation in breast and colorectal cancer patients presenting with high BMI and not severely malnourished but undergoing the stress of surgery would be beneficial in terms of nutritional and clinical outcomes. Trial registration ClinicalTrial.gov NCT04400552. Registered on 22 May 2020, retrospectively registeredhttps://doi.org/10.1186/s13063-021-05716-5Perioperative oral nutrition supplementBreast cancerColorectal cancerNon-severe malnutritionSurgical outcomes
spellingShingle T. X. Wong
S. T. Chen
S. H. Ong
S. Shyam
P. Kandasami
W. S. S. Chee
Study protocol for an open labelled randomised controlled trial of perioperative oral nutrition supplement in breast and colorectal cancer patients undergoing elective surgery
Trials
Perioperative oral nutrition supplement
Breast cancer
Colorectal cancer
Non-severe malnutrition
Surgical outcomes
title Study protocol for an open labelled randomised controlled trial of perioperative oral nutrition supplement in breast and colorectal cancer patients undergoing elective surgery
title_full Study protocol for an open labelled randomised controlled trial of perioperative oral nutrition supplement in breast and colorectal cancer patients undergoing elective surgery
title_fullStr Study protocol for an open labelled randomised controlled trial of perioperative oral nutrition supplement in breast and colorectal cancer patients undergoing elective surgery
title_full_unstemmed Study protocol for an open labelled randomised controlled trial of perioperative oral nutrition supplement in breast and colorectal cancer patients undergoing elective surgery
title_short Study protocol for an open labelled randomised controlled trial of perioperative oral nutrition supplement in breast and colorectal cancer patients undergoing elective surgery
title_sort study protocol for an open labelled randomised controlled trial of perioperative oral nutrition supplement in breast and colorectal cancer patients undergoing elective surgery
topic Perioperative oral nutrition supplement
Breast cancer
Colorectal cancer
Non-severe malnutrition
Surgical outcomes
url https://doi.org/10.1186/s13063-021-05716-5
work_keys_str_mv AT txwong studyprotocolforanopenlabelledrandomisedcontrolledtrialofperioperativeoralnutritionsupplementinbreastandcolorectalcancerpatientsundergoingelectivesurgery
AT stchen studyprotocolforanopenlabelledrandomisedcontrolledtrialofperioperativeoralnutritionsupplementinbreastandcolorectalcancerpatientsundergoingelectivesurgery
AT shong studyprotocolforanopenlabelledrandomisedcontrolledtrialofperioperativeoralnutritionsupplementinbreastandcolorectalcancerpatientsundergoingelectivesurgery
AT sshyam studyprotocolforanopenlabelledrandomisedcontrolledtrialofperioperativeoralnutritionsupplementinbreastandcolorectalcancerpatientsundergoingelectivesurgery
AT pkandasami studyprotocolforanopenlabelledrandomisedcontrolledtrialofperioperativeoralnutritionsupplementinbreastandcolorectalcancerpatientsundergoingelectivesurgery
AT wsschee studyprotocolforanopenlabelledrandomisedcontrolledtrialofperioperativeoralnutritionsupplementinbreastandcolorectalcancerpatientsundergoingelectivesurgery